Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Value Stocks to Buy on the Dip: April 2024

Outside of recent rumblings, the sentiment surge in the equities space this year has taken some of the shine off value stocks to buy on…

The Top 3 Blue-Chip Stocks to Buy in April 2024

With the global economy facing uncertain times, investors ought to position themselves in top blue-chip stocks. No, aligning yourself with the biggest publicly traded companies…

7 Utility Stocks Built to Withstand Market Mayhem

While utility stocks are painfully boring investments, they can steer your portfolio in the right direction during challenging times.

Why Is Biodexa (BDRX) Up 70% Today?

Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher.

AMC Stock: Lenders Push for AMC Debt Extension

While AMC Entertainment may be negotiating its debt payments, AMC stock still faces the broader box office conundrum.